Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Form 8.3 - Plant Impact Plc Amendment

18 Dec 2017 14:59

FORM 8.3

Amendment to section 2(a)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: CQS (UK) LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plant Impact Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13 December 2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ISIN GB00B1F4K366

1p Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 8,811,208 9.31
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

8,811,208 9.31

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure: 14 December 2017
Contact name: Sarah Monime
Telephone number: 020 7201 6900

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171218005700/en/

Copyright Business Wire 2017

Date   Source Headline
6th Jan 20162:05 pmRNSDirector's Dealing
30th Nov 20155:08 pmRNSNotification of Major Interest in Shares
25th Nov 20153:09 pmRNSResult of AGM
25th Nov 20157:00 amRNSTrading update
2nd Nov 20152:52 pmRNSAnnual Report and AGM Notice
2nd Nov 20157:00 amRNSPresentation at World Agri-Tech Investment Summit
26th Oct 20157:00 amRNSPreliminary Results
28th Sep 20157:00 amRNSSignificant R&D Appointments
4th Sep 20157:00 amRNSTrading Update
31st Jul 201511:48 amRNSChief Executive Officer's Restricted Share Units
9th Jul 20154:48 pmRNSHolding(s) in Company
3rd Jul 20154:37 pmRNSInvestor Open Day
3rd Jul 20158:00 amRNSDirectors Dealing and Total Voting Rights
3rd Jul 20157:00 amRNSLaunch of Cocoa Yield Enhancement Product
2nd Jul 20154:48 pmRNSBlock Listing Application
3rd Jun 20157:00 amRNSTrading Update
1st Jun 20151:34 pmRNSKey Senior Management Appointments
27th May 20159:38 amRNSHolding(s) in Company
30th Apr 20157:01 amRNSBoard Changes
20th Apr 20152:44 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSDirector's Dealing
26th Mar 20157:00 amRNSInterim Results
6th Mar 201510:03 amRNSHolding(s) in Company
5th Mar 20152:29 pmRNSHolding(s) in Company
5th Mar 20152:24 pmRNSHolding(s) in Company
2nd Mar 20152:26 pmRNSHolding(s) in Company
27th Feb 20157:00 amRNSProposed Placing
16th Feb 20157:00 amRNSSignificant additional Bayer CropScience agreement
9th Feb 20157:00 amRNSTrading Update
1st Dec 20141:56 pmRNSIssue of Equity
20th Nov 20149:53 amRNSResults of AGM
20th Nov 20147:00 amRNSQ1 Trading Update
29th Oct 20142:00 pmRNSAnnual Report & Accounts and Notice of AGM
27th Oct 20147:00 amRNSFinal Results
15th Oct 20143:48 pmRNSHolding(s) in Company
11th Sep 20147:00 amRNSTrading Update
3rd Sep 20142:00 pmRNSCommercial Agreement
14th Jul 20148:20 amRNSHolding(s) in Company
5th Jun 20147:00 amRNSTrading Update
7th May 20149:14 amRNSHolding(s) in Company
28th Apr 20147:00 amRNSInterim Results
4th Mar 20147:00 amRNSTrading Update
14th Feb 20147:00 amRNSAppointment of Peel Hunt as Nomad and Broker
27th Jan 20148:04 amRNSDirector/PDMR Shareholding
16th Jan 201410:48 amRNSResult of AGM
17th Dec 20137:00 amRNSKey Management Appointments
13th Dec 20137:00 amRNSNotice of AGM
21st Nov 20133:01 pmRNSTrading Statement
21st Nov 20132:59 pmRNSFinal Results
21st Nov 20139:39 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.